Abstracts

The End of Oral? How Long-Acting Formulations Are Changing the Management of Infectious Diseases

Presentation: Despite having near-perfect single tablet regimens, adherence to daily oral HIV treatment and prevention is unacceptably low in many settings. Long-acting and extended-release drugs and formulations hold promise for solving this problem and improving outcomes, facilitating the achievement of WHO targets for controlling this epidemic. The first LA/ER formulations for HIV treatment and prevention…

Diagnostics 4.0: The Future of Diagnostics for HIV and Related Infections

Presentation: Overview Since the late 1980s, novel HIV screening and diagnostic technologies have led the way in the field of HIV/STBBIs and changed the landscape of diagnostics in Infectious Diseases. Global interest and awareness of timely testing have translated to an enhanced momentum for developing and growing novel testing technologies and related strategies. Multiplexed (nucleic…

Overview of the Global Displacement Crisis

Presentation: Globally, over 110 million people have been forcibly displaced from their homes due to various factors such as conflict, violence, persecution, and human rights abuses. Displaced people, especially women and children face a heightened risk of sexual violence, exploitation, and trafficking exposing them to increased health risks including exposure to HIV infection. Many face…

Implementation of DoxyPEP: Challenges and Opportunities

Presentation: Doxycycline post-exposure prophylaxis (doxy-PEP) is highly effective in reducing bacterial STIs among men who have sex with men (MSM) and transgender women (TGW). Optimizing the public health impact of this highly effective STI prevention tool while minimizing potential risks will require a multi-pronged, equity-centered implementation strategy. The US Centers for Disease Control and Prevention…

Introduction to DoxyPEP: Understanding the Issues

Presentation: New strategies are needed to address persistently increasing rates of bacterial sexually transmitted infections (STI). Recent trials demonstrate that doxycycline post-exposure prophylaxis (doxy-PEP) significantly reduces the risk of chlamydia, syphilis, and gonorrhea in cisgender men and transgender women who have sex with men. One study found doxy-PEP did not reduce risk for STI in…

DoxyPEP: Should We Worry About Antimicrobial Resistance?

Presentation: Increased rates of bacterial sexually transmitted infections (STIs) are reported among men who have sex with men (MSM), particularly among those using HIV pre-exposure prophylaxis (PrEP). Interventions to reduce the incidence of STIs are needed. In the field of STI prevention using doxycycline on-demand post-exposure prophylaxis (PEPdoxy), we are witnessing significant advances. Three large-scale…

How New WHO Guidance Can Transform Hepatitis B in Sub-Saharan Africa

Presentation: The presentation will provide the latest epidemiology of HBV in sub-Saharan Africa (including Hepatitis delta) and highlight the unique consideration and status of elimination (and comparison to other regions); recent evidence related to reducing new infection (HB PMTCT); strategies for transforming the HBV public health response; and highlights from the updated 2024 WHO guidelines…

Advances in HBV Immunotherapy: The Beginning of the End?

Presentation: Encouraging data demonstrates that new combination therapies are beginning to achieve HBsAg loss in a significant proportion of chronic hepatitis B (CHB) patients. In some patients, HBsAg loss is durable, achieving functional cure, while others relapse, with HBsAg becoming detectable again during follow up. What determines cure vs. relapse remains unclear but, in the…

Virion Disassembly: Keeping it Together Until the Right Moment

Presentation: HIV has a core built of around 250 capsid protein hexamers and exactly 12 pentamers. This cone shaped core contains the viral single stranded RNA genome which is converted into a double stranded DNA genome by encapsidated reverse transcription, catalysed by viral reverse transcriptase. Early data suggested that viral capsids come apart or ‘uncoat’…